You are here

Conclusion and Further Reading - Chapter 19

Chapter 19 - Renal Cell Cancer

Conclusion

Many elderly patients require special considerations when devising a treatment plan. Age-related physiological, cognitive, and social factors seen in this patient population may influence treatment selection, goals of treatment, response to therapy, and the management of adverse effects. However, none of these factors should necessarily preclude an elderly patient from receiving treatment with targeted therapies. With a proper understanding of these particular considerations and the biology underlying RCC, appropriate preparation, patient education, and regular monitoring for and management of adverse effects can allow elderly patients with RCC to benefit from such therapies. The new immunotherapeutic approaches (mainly the anti PD-1/PD-L1 compounds) bring new and promising treatment opportunities in the elderly patient population due to their tolerability profile and merit further exploration in the subgroup of elderly patients with mRCC.

Further Reading

« Previous Page Next Page »